New Zealand markets close in 1 hour 53 minutes

BIIB Apr 2023 230.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
42.500.00 (0.00%)
As of 02:57PM EDT. Market open.
Full screen
Previous close42.50
Expiry date2023-04-21
Day's range42.50 - 42.50
Contract rangeN/A
Open interest15
  • GlobeNewswire

    Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS

    SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United StatesCAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). On the question, “Is the available evidenc

  • Zacks

    Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know

    Biogen Inc. (BIIB) closed the most recent trading day at $266.15, moving -0.66% from the previous trading session.

  • Motley Fool

    Should You Buy Biogen Before a Big July Decision?

    Over time, Biogen (NASDAQ: BIIB) created a true success story. Competition for Biogen's MS blockbuster Tecfidera, and for other key products, entered the market. Now, though, Biogen may have found that new growth source.